cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Perrigo Company Public Limited Company
3 own
7 watching
Current Price
$36.5
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
4,912.9M
52-Week High
52-Week High
43.9
52-Week Low
52-Week Low
30.78
Average Volume
Average Volume
0.02M
Dividend Yield
Dividend Yield
0.02038
P/E Ratio
P/E Ratio
54.78
iconMarket Capitalization4,912.9M
icon52-Week High43.9
icon52-Week Low30.78
iconAverage Volume0.02M
iconDividend Yield0.02038
iconP/E Ratio54.78
What does the Perrigo Company Public Limited Company do?
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Read More
How much money does Perrigo Company Public Limited Company make?
News & Events about Perrigo Company Public Limited Company.
PR Newswire
1month ago
Perrigo to Host Virtual Investor Day on February 28, 2023 Perrigo to Host Virtual Investor Day on February 28, 2023 PR Newswire DUBLIN, Dec. 19, 2022 DUBLIN, Dec. 19, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced...
Globe Newswire
1month ago
Stolkholms Best Kept Skincare Secret Is The Perfect Gift For Giving SENSITIVE BALANCE STARTER KIT - SRP: $95 USD Say goodbye to redness while you soothe, nourish and strengthen sensitive skin with this starter set. Includes: Sensitive Balance Eye Cream: soothing and moisturizing with prebiotics...
PR Newswire
3 months ago
Perrigo Announces Quarterly Dividend Perrigo Announces Quarterly Dividend PR Newswire DUBLIN, Nov. 3, 2022 DUBLIN, Nov. 3, 2022 /PRNewswire/ --Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly...
PR Newswire
4 months ago
PERRIGO ANNOUNCES JOINT FDA ADVISORY COMMITTEE TO REVIEW OPILL DAILY ORAL CONTRACEPTIVE FOR OVER-THE-COUNTER (OTC) USE PERRIGO ANNOUNCES JOINT FDA ADVISORY COMMITTEE TO REVIEW OPILL DAILY ORAL CONTRACEPTIVE FOR OVER-THE-COUNTER (OTC) USE PR Newswire DUBLIN, Sept. 12, 2022 DUBLIN, Sept. 12, 2022...
Frequently Asked Questions
Frequently Asked Questions
What is Perrigo Company Public Limited Company share price today?
plus_minus_icon
Can Indians buy Perrigo Company Public Limited Company shares?
plus_minus_icon
How can I buy Perrigo Company Public Limited Company shares from India?
plus_minus_icon
Can Fractional shares of Perrigo Company Public Limited Company be purchased?
plus_minus_icon
What are the documents required to start investing in Perrigo Company Public Limited Company stocks?
plus_minus_icon
What is today’s traded volume of Perrigo Company Public Limited Company?
plus_minus_icon
What is today’s market capitalisation of Perrigo Company Public Limited Company?
plus_minus_icon
What is the 52-Week High and Low Range of Perrigo Company Public Limited Company?
plus_minus_icon
What percentage is Perrigo Company Public Limited Company down from its 52-Week High?
plus_minus_icon
What percentage is Perrigo Company Public Limited Company up from its 52-Week Low?
plus_minus_icon
Current Price
$36.5
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
$40.23
$-0.74 (-1.81 %)
Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc.
$47.10
$-0.17 (-0.36 %)
Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
$47.96
$0.32 (0.67 %)
Novartis AG
Novartis AG
$87.10
$0.00 (0.00 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
$40.23
$-0.74 (-1.81 %)
Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc.
$47.10
$-0.17 (-0.36 %)
Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
$47.96
$0.32 (0.67 %)
Novartis AG
Novartis AG
$87.10
$0.00 (0.00 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00